Government of Canada signs bilateral agreement with New Brunswick to improve access to drugs for rare diseases
- Published: 2025-01-15 14:10
- Source: Canada All National News
Today, the Government of Canada and the Government of New Brunswick signed a bilateral agreement to improve access to drugs for rare diseases. This agreement is part of the government’s commitment to providing all Canadians with access to the medications they need.
The agreement will provide up to $100 million over five years to help New Brunswick improve access to drugs for rare diseases. This funding will be used to:
- Increase the number of drugs covered by the province’s public drug plan
- Reduce the cost of drugs for patients
- Improve access to specialized care for patients with rare diseases
“This agreement is an important step forward in our efforts to improve access to drugs for rare diseases,” said the Honourable Patty Hajdu, Minister of Health. “We are committed to working with provinces and territories to ensure that all Canadians have access to the medications they need.”
“This agreement will make a real difference in the lives of New Brunswickers with rare diseases,” said the Honourable Dorothy Shephard, Minister of Health for New Brunswick. “We are grateful to the Government of Canada for its support.”
The bilateral agreement is part of the government’s broader efforts to improve access to drugs for rare diseases. In 2019, the government announced a $1 billion investment over 10 years to create a national strategy for drugs for rare diseases. This strategy will help to improve access to drugs, research, and care for patients with rare diseases.
What are rare diseases?
Rare diseases are conditions that affect a small number of people. In Canada, a rare disease is defined as a condition that affects fewer than 1 in 2,000 people. There are over 7,000 known rare diseases, and they can affect people of all ages.
What are the challenges of accessing drugs for rare diseases?
There are a number of challenges to accessing drugs for rare diseases. These challenges include:
- The high cost of drugs
- The limited availability of drugs
- The lack of research on rare diseases
How can the bilateral agreement help?
The bilateral agreement will help to address some of the challenges of accessing drugs for rare diseases. The funding will be used to:
- Increase the number of drugs covered by the province’s public drug plan
- Reduce the cost of drugs for patients
- Improve access to specialized care for patients with rare diseases
This agreement is an important step forward in improving access to drugs for rare diseases. The government is committed to working with provinces and territories to ensure that all Canadians have access to the medications they need.
Government of Canada signs bilateral agreement with New Brunswick to improve access to drugs for rare diseases
The AI has provided us with the news.
I’ve asked Google Gemini the following question, and here’s its response.
Canada All National News a new article on 2025-01-15 14:10 titled “Government of Canada signs bilateral agreement with New Brunswick to improve access to drugs for rare diseases”. Please write a detailed article on this news item, including any relevant information. Answers should be in English.
110